Aurobindo Pharma Board Approves ₹800 Crore Share Buyback Plan
In a strategic move that caught the attention of investors, Aurobindo Pharma's board has greenlit a substantial share buyback plan worth ₹800 crore. This development is set to influence the market sentiment around the pharmaceutical company, reflecting [...]
